17.59
前日終値:
$17.20
開ける:
$17.1
24時間の取引高:
65.34M
Relative Volume:
1.59
時価総額:
$33.69B
収益:
$15.01B
当期純損益:
$1.43B
株価収益率:
23.64
EPS:
0.744
ネットキャッシュフロー:
$1.63B
1週間 パフォーマンス:
+3.15%
1か月 パフォーマンス:
+3.08%
6か月 パフォーマンス:
-20.25%
1年 パフォーマンス:
-16.85%
Kenvue Inc Stock (KVUE) Company Profile
名前
Kenvue Inc
電話
908-874-1200
住所
1 KENVUE WAY, SUMMIT
KVUE を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
KVUE
Kenvue Inc
|
17.59 | 32.95B | 15.01B | 1.43B | 1.63B | 0.744 |
|
PG
Procter Gamble Co
|
146.97 | 337.73B | 84.93B | 16.86B | 14.94B | 6.8506 |
|
UL
Unilever Plc Adr
|
64.91 | 140.68B | 64.99B | 6.71B | 6.53B | 2.74 |
|
CL
Colgate Palmolive Co
|
85.45 | 68.13B | 20.10B | 3.04B | 3.44B | 3.569 |
|
EL
Estee Lauder Cos Inc
|
114.46 | 41.46B | 14.42B | -930.00M | 1.05B | -2.5832 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-29 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | アップグレード | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | 開始されました | Redburn Atlantic | Neutral |
| 2025-03-24 | 開始されました | Evercore ISI | In-line |
| 2025-01-06 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-09-24 | 開始されました | Jefferies | Buy |
| 2024-09-24 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | 再開されました | Citigroup | Neutral |
| 2024-04-11 | 開始されました | Bernstein | Underperform |
| 2024-04-03 | 開始されました | William Blair | Mkt Perform |
| 2024-03-01 | 再開されました | Goldman | Neutral |
| 2023-11-17 | 開始されました | Piper Sandler | Neutral |
| 2023-09-11 | アップグレード | Deutsche Bank | Hold → Buy |
| 2023-09-07 | 開始されました | Canaccord Genuity | Buy |
| 2023-09-06 | 開始されました | Argus | Hold |
| 2023-08-24 | アップグレード | Goldman | Neutral → Buy |
| 2023-07-25 | 開始されました | Edward Jones | Buy |
| 2023-06-01 | 開始されました | HSBC Securities | Hold |
| 2023-05-30 | 開始されました | BofA Securities | Buy |
| 2023-05-30 | 開始されました | Citigroup | Neutral |
| 2023-05-30 | 開始されました | Deutsche Bank | Hold |
| 2023-05-30 | 開始されました | Exane BNP Paribas | Neutral |
| 2023-05-30 | 開始されました | Goldman | Neutral |
| 2023-05-30 | 開始されました | JP Morgan | Overweight |
| 2023-05-30 | 開始されました | RBC Capital Mkts | Outperform |
| 2023-05-30 | 開始されました | UBS | Neutral |
すべてを表示
Kenvue Inc (KVUE) 最新ニュース
Kenvue stock ticks up as investors size up Kimberly-Clark takeover vote in days - TechStock²
Activist investors do not plan to play nice this year as they eye more corporate breakups - marketscreener.com
Analysts Offer Insights on Consumer Goods Companies: Kenvue, Inc. (KVUE) and McCormick & Company (MKC) - The Globe and Mail
A Look Into Kenvue Inc's Price Over Earnings - Benzinga
Is Johnson & Johnson A Dividend Stock, Or Something Else? (NYSE:JNJ) - Seeking Alpha
Massachusetts Financial Services Co. MA Sells 3,862,828 Shares of Kenvue Inc. $KVUE - MarketBeat
Published on: 2026-01-19 01:22:15 - baoquankhu1.vn
Portfolio Recap: Can Kenvue Inc weather a recession2025 Investor Takeaways & Short-Term Swing Trade Alerts - baoquankhu1.vn
Kenvue stock has a new catalyst: ISS backs Kimberly-Clark merger ahead of Jan. 29 vote - TechStock²
Tylenol Pregnancy Study Contradicts Trump Claims on Autism Link - Bloomberg.com
Kenvue's Study Finds No Autism Link with Acetaminophen Use During Pregnancy - Intellectia AI
No link between autism and Tylenol: new study (KVUE:NYSE) - Seeking Alpha
Kenvue stock: ISS backs Kimberly-Clark deal as lawsuit filings add pressure ahead of vote - TechStock²
Kenvue Inc. $KVUE Shares Sold by SG Americas Securities LLC - MarketBeat
Kenvue Inc. $KVUE Shares Purchased by Arlington Partners LLC - MarketBeat
Tylenol pregnancy study contradicts Trump's claims on link with autism - Business Standard
The New York Stock Exchange | NYSE - NYSE
Kenvue Supplements Proxy Disclosures Ahead of Merger Vote - TipRanks
KIMBERLY CLARK CORP Announces Merger with Kenvue - TradingView — Track All Markets
KMB SEC FilingsKimberly-Clark Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Lobbying Update: $60,000 of KENVUE INC. lobbying was just disclosed - Quiver Quantitative
ISS Recommends Approval of Kimberly-Clark's $49B Kenvue Acquisition - Intellectia AI
ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal | Business Information & News | FE - Westlaw Today
ISS recommends shareholders approve Kimberly-Clark's planned Kenvue deal - MSN
TD Private Client Wealth LLC Reduces Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Trading Systems Reacting to (KVUE) Volatility - Stock Traders Daily
Kenvue stock is up today — here’s what the Kimberly-Clark deal is worth now - TechStock²
Assessing Kenvue (KVUE) Valuation As Short Term Share Price Momentum Improves - Yahoo Finance
Kenvue stock edges up as Kimberly-Clark vote nears — the deal spread traders are watching - TechStock²
Nisa Investment Advisors LLC Sells 66,610 Shares of Kenvue Inc. $KVUE - MarketBeat
RBC Capital Sticks to Their Hold Rating for Kenvue, Inc. (KVUE) - The Globe and Mail
Insider Sell: Can Kenvue Inc stock continue upward trend2025 Volume Leaders & Safe Capital Growth Tips - moha.gov.vn
Kenvue (NYSE: KVUE) outlines Kimberly-Clark merger proxy and risks - Stock Titan
2 No-Brainer Dividend Stocks to Buy Right Now - The Motley Fool
ETF Watch: Can Kenvue Inc expand into new marketsJuly 2025 Breakouts & Fast Momentum Entry Tips - baoquankhu1.vn
Momentum Shift: Is Kenvue Inc a cyclical or defensive stockJuly 2025 News Drivers & Low Risk Entry Point Guides - baoquankhu1.vn
Sumitomo Mitsui DS Asset Management Company Ltd Increases Stock Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock lags Kimberly-Clark offer value as deal vote and earnings line up - TechStock²
Alley Investment Management Company LLC Sells 123,556 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue faces class action over Johnson’s baby oil labeling - Global Cosmetics News
Kenvue stock (KVUE) ends week lower as Jan. 29 Kimberly-Clark deal vote nears - TechStock²
Park Avenue Securities LLC Sells 96,606 Shares of Kenvue Inc. $KVUE - MarketBeat
Kimberly-Clark Strikes $40 Billion Deal for Tylenol Maker Kenvue - MSN
Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal - MSN
Kenvue stock countdown: Jan. 29 merger vote looms as KVUE deal spread stays jumpy - TechStock²
Kimberly-Clark And Kenvue Merger: Great Value Based On Combined Financials (NYSE:KVUE) - Seeking Alpha
Kenvue stock: Options memo spotlights Jan. 29 vote on Kimberly-Clark deal - TechStock²
Kenvue board names Kirk Perry as CEO on permanent basis - MSN
Earnings Preview: Anticipating Kenvue’s Upcoming Results - Bitget
Kenvue Is Considering Selling Some Brands, Reuters Reports - MSN
Kenvue’s winter skin care strategy: Merging ingredient innovation and digital personalization - Personal Care Insights
Kenvue Inc (KVUE) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):